Abstract
DL 473 is a 3-[(4-cyclopentyl-1-piperazinyl)iminomethyl] rifamycin SV derivative which inhibited staphylococci, streptococci (including Streptococcus faecalis, Listeria species, and Bacteroides species. DL 473 was less active than rifampin against these species. DL 473 did not inhibit Enterobacteriaceae nor most Pseudomonas species. A combination of DL 473 and vancomycin or nafcillin tested against staphylococci was primarily additive and antagonism was not encountered.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Arioli V., Berti M., Carniti G., Randisi E., Rossi E., Scotti R. Antibacterial activity of DL 473, a new semisynthetic rifamycin derivative. J Antibiot (Tokyo) 1981 Aug;34(8):1026–1032. doi: 10.7164/antibiotics.34.1026. [DOI] [PubMed] [Google Scholar]
- Assandri A., Perazzi A., Berti M. Studies of binding C3-substitute rifamycins to human and bovine serum albumin. J Antibiot (Tokyo) 1977 May;30(5):409–415. doi: 10.7164/antibiotics.30.409. [DOI] [PubMed] [Google Scholar]
- Birmingham A. T., Coleman A. J., Orme M. L., Park B. K., Pearson N. J., Short A. H., Southgate P. J. Antibacterial activity in serum and urine following oral administration in man of DL473 (a cyclopentyl derivative of rifampicin) [proceedings]. Br J Clin Pharmacol. 1978 Nov;6(5):455P–456P. doi: 10.1111/j.1365-2125.1978.tb04626.x. [DOI] [PubMed] [Google Scholar]
- Cricchio R., Arioli V., Lancini G. C. Hydrazones of 3-formylrifamycin SV. I - Hydrazones with N-amino-N'-substituted piperazines: synthesis, antibacterial activity and other biological properties. Farmaco Sci. 1975 Aug;30(08):607–619. [PubMed] [Google Scholar]
- Ridgway G. L., Oriel J. D. Activity of antimicrobials against Chlamydia trachomatis in vitro. J Antimicrob Chemother. 1979 Jul;5(4):483–484. doi: 10.1093/jac/5.4.483. [DOI] [PubMed] [Google Scholar]